Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes. - Katsuki,A.; Sumida,Y.; Murata,K.; Furuta,M.; Araki-Sasaki,R.; Tsuchihashi,K.; Hori,Y.; Yano,Y.; Gabazza,E.C.; Adachi,Y. (Diabetes Obes Metab, 2000)